Xenon Pharmaceuticals Inc (NASDAQ:XENE)
| 30.59 BATS BZX Real-Time Price As of 1:51pm ET |  +0.76 / +2.55%Today’s Change | 9.32 Today|||52-Week Range 34.87 | +98.89% Year-to-Date |
Latest XENE News | Press Releases
| 3 Growth Stocks Near 52-Week Highs to Buy Anyway Oct 14 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 29.83 |
| Today’s open | 29.95 |
| Day’s range | 29.90 - 31.10 |
| Volume | 19,040 |
| Average volume (3 months) | 1,486,342 |
| Market cap | $1.7B |
Data as of 1:51pm ET, 10/20/2021
Growth & Valuation
| Earnings growth (last year) | +47.44% |
| Earnings growth (this year) | -105.76% |
| Earnings growth (next 5 years) | +61.10% |
| Revenue growth (last year) | +371.02% |
| P/E ratio | NM |
| Price/Sales | 16.52 |
| Price/Book | 7.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INOInovio Pharmaceutica... | -0.08 | -1.12% |
| ---- | ||
| SUPNSupernus Pharmaceuti... | +0.46 | +1.55% |
| ---- |
Data as of 1:51pm ET, 10/20/2021
Financials
| Next reporting date | November 9, 2021 |
| EPS forecast (this quarter) | -$0.37 |
| Annual revenue (last year) | $32.2M |
| Annual profit (last year) | -$28.8M |
| Net profit margin | -89.65% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Burnaby, British Columbia |
Forecasts
